Avastin, Her2, and insurance

BearMan52 · 01-15-2009, 07:38 AM

Hey Gang,
We're needing to make a treatment switch in our recurrence battle. Have been on Taxotere/Carbo/Herceptin; Navelbine/Herceptin; Xeloda/Tykerb; Femara; with Zometa throughout.

What we planned next was Abraxene/Avastin, but our insurance (Anthem-BC/BS) denied the Avastin for two reasons:
1. no study data available for Avastin in Her2-positive (which we obviuosly are)
2. we're not using it as our first line

Any help? I see many on these boards have been on Avastin. Obviously some companies approved its use for Her2-pos?? And I'm wondering if anyone else had to fight for it.

Thanks for any help!
Barry
Caregiver Husband

chrisy · 01-16-2009, 01:32 PM

Hi Barry,

The FDA approved indication for Avastin is, as you probably know, for first line. However many people have been able to get it - Sheila has been on Taxol/Avastin (her BCBS denied the Abraxane!) but I think that was just prior to the FDA approval. At any rate, it was "off label" when she got it.

I'm curious as to why no Her2 targeting agent is included in your proposed therapy?

This was a poster presented at San Antonio showing efficacy/safety of Avastin/Tykerb in Her2+ patients. I was on this study and did OK (stable for 8 months), but I know others here were on the same study until it closed and it was a very successful therapy.

More research is ongoing I'm sure, and there may be other data out there in other scenarios, but for your purposes this may serve as a small rebuttal to the "no study data available for Avastin in Her2+" excuse.

http://www.posters2view.com/sabcs08/viewp.php?nu=3133

Good luck, keep up the fight!

BearMan52 · 01-16-2009, 03:19 PM

Hi Chrisy,
Thanks much for the info...and some rebuttal ammo. Re. any Her2 targeted therapy at present, our doc is thinking we've burned through Herceptin and Tykerb, at least for now. Herceptin was in the regimen for a year, then Tykerb another year. Each did the trick for awhile, but then some progression. I do wonder about any adjuvant advantage---keeping the cancer from any new fronts, with the Her2 therapies.
Thanks!
Barry

Joe · 01-16-2009, 03:31 PM

Barry,

You may wish to consider entering a clinical trial of Herceptin DM1. Several members are having great results and you will not be charged for the drug.

Clinical Trials

Regards
Joe

BearMan52 · 01-16-2009, 09:37 PM

Joe,
I'll give that a look...thanks much!
Barry

Sheila · 01-17-2009, 10:57 AM

Barry
My insurance denied the Abraxane as it was too expensive , then denied the Avastin when they realized they were paying for something that wasn't approved by the FDA for breast cancer....I had excellent results from the combo of Taxol Avastin, Herceptin, but my Blood Pressure just kept on rising even with the addition of B/P meds...so best that I went off it...just a FYI...i have been on herceptin 5 1/2 years, 3 with chemo added...when i show progression in my nodes, they change the chemo and keep the Herceptin...so far still fighting!

BearMan52 · 01-17-2009, 09:13 PM

Hi Sheila,
Thanks for the info! That's interesting to hear about staying on Herceptin, even with progression. I like that idea...it makes sense. Thanks muhc!
Barry

01-18-2009, 10:16 PM

Hi Barry,

There have been studies showing that continuing Herceptin beyond progression improves survival. I believe that one of these studies may be in the abstracts from San Antonio. If it is not there, then it was probably presented at Asco.

Sorry, but I have no insight on your insurance question. But I would ask about continuing either Herceptin or Tykerb.

Best regards,

Jill

julierene · 01-26-2009, 10:55 AM

An Open Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 (T-DM1) in Patients Previously Treated With T-DM1 in a Genentech Sponsored T-DM1 Study

I am so confused! What is this study?

chrisy · 01-26-2009, 05:33 PM

Julierene
This is a study to follow people who have "completed" a previous trial with T-DM1. This new study is to enable them to continue to follow these patients - I think the endpoints are time to progression and ocurrence of significant adverse events.

For example if you were on a T-DM1 study that had a protocol of you being treated for 1 year, when you complete the year you could roll over into the new study.

julierene · 01-27-2009, 07:03 AM

Thanks for the information! That makes sense now.

I am actually getting ready to have the same problem likely with Blue Cross. I sure hope not. But will they rule any different here in Texas? My oncologist is warning me that it will be a fight to get Avastin. But my monthly scan is tomorrow and I hope to God there are some good results, or I will be fighting for the Avastin. What recourse do we have against the insurance company? Are there organizations out there who will pay for this? In my situation, I am running out of approved treatments. I can't afford to get in a trial and run to different cities and states. I have 3 children and I just feel like I will be out of options soon. Ugh!

Joe · 01-27-2009, 07:35 AM

To all:

I cannot recommend highly enough the Cancer Legal Resource Center .

Although they are located in Los Angeles, they assist cancer patients throughout the country and are pro-bono

Regards
Joe

julierene · 03-26-2009, 06:40 AM

Avastin was approved, and will be next for me with Ixempra. After telling my onc that I had a very large area of red, warm skin above where my tumor was - he felt even more confident that my cancer will respond well to Avastin. I am getting pretty nervous. I just got my CT results, and the radiologist thinks the cancer is slightly increased because of the density. According to the scan two months ago, things look denser. But I just had a tumor marker drop 50 points a month ago. So the oncologist is crossing his fingers for a good tumor marker result by Friday. He said if it's dowm, then the denser look on the CT is from necrosis. Man, I am on pins and needles!

BearMan52 · 03-26-2009, 07:08 AM

Julierene,
We KNOW those pins and needles...interesting about the red, warm skin and the Avastin connection.

We ended up getting a compassionate release from Genentech, but meanwhile were having good results from Abraxene alone, so we've stayed single-agent for now and will add Avastin if it looks like we need to add an extra punch.

Praying/hoping for a good tumor marker result on Friday!
Barry

julierene · 03-26-2009, 08:36 AM

My onc said that Avastin and Herceptin wouldn't be approved b/c there wasn't enough data to support that it would even be well tolerated. He said the insurance co's wouldn't shell out $10K a week on a treatment that likely wouldn't do any better by seeing what they do by themselves. He said either Tykerb works or it doesn't. Either Herceptin works or it doesn't. Either Avastin works or it doesn't. Is it really that simple? He said if Herceptin doesn't work anymore, why keep taking it? I said, what about synnergy? He said if the receptors are killed off, the medicine won't work anymore... period.

Ellie F · 03-26-2009, 11:00 AM

Hi can anyone explain what Julierene's onc meant about receptors being killed off. My new onc is very enthusiastic about synergy but I have never heard about the her2 receptors going.Does this happen if you have many different drug combos or just a particular drug. Anyone got info on this??Ellie

julierene · 03-26-2009, 12:55 PM

I think it's just the theory that Herceptin and Tykerb block all the receptors, the immune system kills off all those cells, then you are left with whatever is left. They theorize that at microscopic levels, you can have many different types of cells, some having less receptors than others. Once you have effectively cleared out all the cancer with receptors, you can end up with cells that have different receptors. As receptors change to evade the immune system, so does the nature of the cancer. It's like the part of the cellular structure that works against people who have cancer. In normal healthy cells, this process is survival. But the natural programmed cellular structure, is now cancerous, and working against what we want. That's why Tykerb works when Herceptin fails. It's a new way to target when the receptors on the outside of the cell seem to not respond to Herceptin anymore. Then when Tykerb clears out the receptors that are on the inside, then there are cells left that don't respond to either... At that point, you start running out of targeted therapies. Avastin is a monoclonal antibody against vascular endothelial growth factor-A (VEGF-A).[1] It is used to inhibit tumor growth by blocking the formation of new blood vessels (angiogenesis). Since HER2 disease has shown trend to being very vascular, this makes sense. P53 targeted therapy also makes a lot of sense. But figuring out whichever direction you go after Tykerb and Herceptin fail, is a mystery to me.

Becky · 03-26-2009, 06:37 PM

A school of thought on Her2 targeted therapies (Herceptin and Tykerb) is that if you are Her2+, your regime should always contain one of the Her2 drugs. They help.

Second, I notice that Femara has always been in the mix. If this has never been changed, you should talk to your onc about trying Aromosin or even Faslodex. Your antihormonal could be the resistant culprit too.